OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
Minglei Zhao, Hui Huang, Feng He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Minglei Zhao, Hui Huang, Feng He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Showing 17 citing articles:
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
Kang Wang, Yan‐Jun Xiang, Hongming Yu, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 708-715
Closed Access | Times Cited: 52
Kang Wang, Yan‐Jun Xiang, Hongming Yu, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 708-715
Closed Access | Times Cited: 52
Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Harnessing Immunotherapy for Hepatocellular Carcinoma: Principles and Emerging Promises
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access | Times Cited: 1
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access | Times Cited: 1
Hepatocellular Carcinoma in Patients with Chronic Hepatitis C and Liver Cirrhosis Treated with DAA: A Focused Review
Săndica Bucurică, Andreea-Simona Nancoff, Raluca Ioana Marin, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1505-1505
Open Access
Săndica Bucurică, Andreea-Simona Nancoff, Raluca Ioana Marin, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1505-1505
Open Access
Comparison of efficacy and safety of adjuvant therapies versus sorafenib in hepatocellular carcinoma: a systematic review and network meta-analysis
Wenying Quan, Hanifah Fazlin Zulkifli, Nazamid Saari, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Wenying Quan, Hanifah Fazlin Zulkifli, Nazamid Saari, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
HCC-derived CX3CL1 affects hepatocellular carcinoma prognosis and CX3CR1 + MDSC infiltration
Xiaoling Zhang, Yidan Lou, Song Zheng, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Xiaoling Zhang, Yidan Lou, Song Zheng, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study
Yilin Wang, Shida Pan, Jiahe Tian, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 6
Open Access
Yilin Wang, Shida Pan, Jiahe Tian, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 6
Open Access
Metabolomics Biomarker Discovery to Optimize Hepatocellular Carcinoma Diagnosis: Methodology Integrating AutoML and Explainable Artificial Intelligence
Fatma Hilal Yağın, Radwa El Shawi, Abdulmohsen Algarni, et al.
Diagnostics (2024) Vol. 14, Iss. 18, pp. 2049-2049
Open Access | Times Cited: 2
Fatma Hilal Yağın, Radwa El Shawi, Abdulmohsen Algarni, et al.
Diagnostics (2024) Vol. 14, Iss. 18, pp. 2049-2049
Open Access | Times Cited: 2
Immune Checkpoint Inhibitor-Induced Liver Injury
Cathrin Gudd, Roosey Sheth, Mark Thursz, et al.
Seminars in Liver Disease (2023) Vol. 43, Iss. 04, pp. 402-417
Closed Access | Times Cited: 5
Cathrin Gudd, Roosey Sheth, Mark Thursz, et al.
Seminars in Liver Disease (2023) Vol. 43, Iss. 04, pp. 402-417
Closed Access | Times Cited: 5
Role of immunotherapies and stem cell therapy in the management of liver cancer: A comprehensive review
Fares E.M. Ali, Islam M. Ibrahim, Hanan S. Althagafy, et al.
International Immunopharmacology (2024) Vol. 132, pp. 112011-112011
Closed Access | Times Cited: 1
Fares E.M. Ali, Islam M. Ibrahim, Hanan S. Althagafy, et al.
International Immunopharmacology (2024) Vol. 132, pp. 112011-112011
Closed Access | Times Cited: 1
Research trends and hotspots in the immune microenvironment related to hepatocellular carcinoma: A bibliometric and visualization study
Da-Ya Zhang, Feihu Bai
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 7, pp. 3321-3330
Open Access | Times Cited: 1
Da-Ya Zhang, Feihu Bai
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 7, pp. 3321-3330
Open Access | Times Cited: 1
Combined transarterial chemoembolization and tislelizumab for patients with unresectable hepatocellular carcinoma
Bin-Bin Tan, Ying Fu, Minghua Shao, et al.
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 9, pp. 2829-2841
Closed Access | Times Cited: 1
Bin-Bin Tan, Ying Fu, Minghua Shao, et al.
World Journal of Gastrointestinal Surgery (2024) Vol. 16, Iss. 9, pp. 2829-2841
Closed Access | Times Cited: 1
Immunomodulatory effects of Fructus corni acidic polysaccharide and its selenium nanoparticles composites in hepatocellular carcinoma
Haiyan Lan, Jie Xu, Zong Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136818-136818
Closed Access | Times Cited: 1
Haiyan Lan, Jie Xu, Zong Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136818-136818
Closed Access | Times Cited: 1
Machine learning-based ultrasomics for predicting response to tyrosine kinase inhibitor in combination with anti-PD-1 antibody immunotherapy in hepatocellular carcinoma: a two-center study
Yiwen Hu, Linlin Zhang, Qinghua Qi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Yiwen Hu, Linlin Zhang, Qinghua Qi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Immune microenvironment in hepatocellular carcinoma: current concepts and the role of blockade of immune checkpoints
Е. Л. Буеверова, O. Yu. Zolnikova, M.A. Paltzev
Molekulyarnaya Meditsina (Molecular medicine) (2024) Vol. 22, Iss. 1, pp. 3-11
Closed Access
Е. Л. Буеверова, O. Yu. Zolnikova, M.A. Paltzev
Molekulyarnaya Meditsina (Molecular medicine) (2024) Vol. 22, Iss. 1, pp. 3-11
Closed Access
The Risk Signature of Pyroptosis-Related Long Noncoding RNAs Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular carcinoma
Wenjie Zhang, Xu Chen, Qiang Meng, et al.
Research Square (Research Square) (2024)
Open Access
Wenjie Zhang, Xu Chen, Qiang Meng, et al.
Research Square (Research Square) (2024)
Open Access
The Characteristics of Transcription Factors Regulating T Cell Exhaustion Were Analyzed to Predict the Prognosis and Therapeutic Effect in Patients with HCC
Jingbo Li, Kun Zhou, Meng Wu, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 5597-5619
Open Access | Times Cited: 1
Jingbo Li, Kun Zhou, Meng Wu, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 5597-5619
Open Access | Times Cited: 1
Possible Therapies for Hepatocellular Carcinoma—Preparing for the Modern War with the Insidious Enemy
Michał Wasilewicz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12536-12536
Open Access
Michał Wasilewicz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12536-12536
Open Access
